To evaluate the long-term results of high-dose therapy (HDT) in follicular lymphoma, with specific emphasis on the prognostic significance of polymerase chain reaction (PCR)-detectable Bcl-2/IgH rearrangements.
High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up.
Imperial Cancer Research Fund Medical Oncology Unit, Department of Medical Oncology, and Departments of Histopathology and Hematology, St Bartholomew's Hospital, London, United Kingdom.